PMC3422141_01
Anterior segment details - conjunctival hyperemia and anterior chamber intraocular lens (LEFT EYE).. Note: Anterior uveitis after ranibizumab.
opth-6-1201f1.jpg
PMC3422141_01_opth-6-1201f1.jpg
f1-opth-6-1201
Biomicroscopy of the anterior segment of the left eye revealed cells (+2/+4), keratic precipitates (+2/+4), and conjunctival hyperemia without discharge (Figures 1 and 2).
Anterior chamber lens details (LEFT EYE).
opth-6-1201f2.jpg
PMC3422141_01_opth-6-1201f2.jpg
f2-opth-6-1201
Biomicroscopy of the anterior segment of the left eye revealed cells (+2/+4), keratic precipitates (+2/+4), and conjunctival hyperemia without discharge (Figures 1 and 2).
Right eye - mild anterior uveitis with cells.. Note: Anterior uveitis after bevacizumab treatment.
opth-6-1201f3.jpg
PMC3422141_01_opth-6-1201f3.jpg
f3-opth-6-1201
Color retinography and fluorescein angiography showed macular disciform scars on both eyes (Figure 3).
OCT image - active exudative ARMD.. Note: In the beginning of ranibizumab treatment.. Abbreviations: ARMD, age-related macular degeneration; OCT, optical coherence tomography.
opth-6-1201f4.jpg
PMC3422141_01_opth-6-1201f4.jpg
f4-opth-6-1201
Optical coherence tomography images of the left eye revealed involution of choroidal neovascularization from the beginning to the end of anti-VEGF drugs treatment (Figures 4 and 5).
OCT image - inactive ARMD.. Note: In the end of treatment.. Abbreviations: ARMD, age-related macular degeneration; OCT, optical coherence tomography.
opth-6-1201f5.jpg
PMC3422141_01_opth-6-1201f5.jpg
f5-opth-6-1201
Optical coherence tomography images of the left eye revealed involution of choroidal neovascularization from the beginning to the end of anti-VEGF drugs treatment (Figures 4 and 5).